Product
Clobetasol propionate
2 clinical trials
3 indications
Indication
CataractIndication
Chronic skin diseaseIndication
Vulvar Lichen SclerosusClinical trial
A Phase 3, Multicenter, Randomized, Double-Masked Clinical Trial to Assess the Efficacy and Safety of Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% Compared to Placebo in the Treatment of Inflammation and Pain Associated With Cataract SurgeryStatus: Completed, Estimated PCD: 2021-05-19
Clinical trial
Prospective, Randomized, Active-controlled Investigator Initiated Clinical Trial to Demonstrate That the Nd:YAG/Er:YAG Dual Laser Therapy is Effective to Treat Vulvar Lichen Sclerosus and Similar to Standard Treatment With Steroid CreamStatus: Active (not recruiting), Estimated PCD: 2024-05-30